The observed trend toward reduced PFS in APC-mutated tumors aligns with prior studies suggesting that APC truncating mutations may promote tumor aggressiveness through dysregulation of Wnt/β-catenin signaling, a pathway central to colorectal carcinogenesis (22). The gene discussed is APC; the disease is neoplasm.